Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (sJIA): TENDER 52-week data by De Benedetti Fabrizio, Brunner Hermine, Ruperto Nicola, Cuttica R, Malattia Clara, Schneider Rayfel, Woo Patricia, Eleftheriou Despina, Baildam Eileen, Burgos-Vargas Ruben, Dolezalova Pavla, Garay Stella M, Joos Rik, Wulffraat Nico, Zuber Zbyszek, Zulian Francesco, Wouters Carine, Xavier Ricardo M, Zemel Lawrence, Wright Stephen, Kenwright Andy, Martini Alberto, Lovell Daniel

Connect to this object online.